The re-emergence of fentanyl has created a heightened need for clinicians to employ medications designed to treat opioid use disorder (MOUD) and implement harm reduction strategies. 

This activity is designed to provide evidence-based recommendations for the care of our Emergency Department patient population who are facing substance abuse issues. 

This course is complimentary to participate on and is available ONLY to Penn Employees.The goal of the educational activity is to change the paradigm towards more judicious opioid prescribing by providing an overview of the opioid epidemic and identifying strategies for clinicians to safely manage and treat acute and chronic pain, promote adherence to new prescribing guidelines and promote harm reduction with opioid use. New Joint Commission requirements issued January 1, 2018 mandate that our h...

The opioid crisis has invaded every corner of the US. And with the highest rate of overdose death among major cities, Philadelphia has been hit especially hard — a statistic that COVID-19 has only exacerbated. How do you begin to tackle multiple complex public health emergencies? Is there hope for life beyond addiction?Join Penn Medicine faculty as they discuss the inroads being made in this fight. Learn how research on the disease of addiction at Penn is setting new standards of care, driving m...

THERE IS NO FEE TO REGISTER FOR THIS ACTIVITY, HOWEVER REGISTRATION IS REQUIRED.IF YOU HAVE ALREADY RECEIVED CREDIT FOR THIS ACTIVITY, CREDIT CAN NOT BE RE-ISSUED. The Pennsylvania Prescription Drug Monitoring Program (PDMP) and faculty experts from Penn Medicine are offering an education curriculum for prescribers on best practices for using the PDMP and on how to address substance use disorder with patients. We invite you to view these complimentary online educational ...